Letter to the Editor
Letter to the Editor Re: Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence upper tract urothelial carcinoma after radical nephroureterectomy
-
Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy
- Tsung Yu Yu,
- Hung Jen Wang,
- Min Tse Sung,
- Yao Chi Chuang,
- Yen Ta Chen,
- Yuan Tso Cheng,
- Chih Hsiung Kang,
- Hui Ying Liu,
- Yin Lun Chang,
- Hao Lun Luo,
- Volume 31Issue 4International Journal of Urology
- pages: 410-418
- First Published online: January 2, 2024
First published: 29 January 2024
No abstract is available for this article.
REFERENCES
- 1Yu TY, Wang HJ, Sung MT, Chuang YC, Chen YT, Cheng YT, et al. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy. Int J Urol. 2024; 31: 410–419.
- 2Mori K, Hatakeyama S, Enokida H, Miyake H, Kikuchi E, Nishiyama H, et al. Summary of the clinical practice guidelines for upper tract urothelial carcinoma 2023 by the Japanese Urological Association. Int J Urol. 2024; 31: 194–207.
- 3Nogueira LM, Yip W, Assel MJ, Tracey AT, Wong NC, Alvim RG, et al. Survival impact of variant histology diagnosis in upper tract urothelial carcinoma. J Urol. 2022; 208: 813–820.
- 4Fontugne J, Xylinas E, Krucker C, Dixon V, Groeneveld CS, Pinar U, et al. Transcriptomic profiling of upper tract urothelial carcinoma: bladder cancer consensus classification relevance, molecular heterogeneity, and differential immune signatures. Mod Pathol. 2023; 36:100300.
